ID	Gene Name	Species	BIOCARTA	COG_ONTOLOGY	GAD_DISEASE	GAD_DISEASE_CLASS	GOTERM_BP_DIRECT	GOTERM_CC_DIRECT	GOTERM_MF_DIRECT	INTERPRO	KEGG_PATHWAY	OMIM_DISEASE	PIR_SUPERFAMILY	SMART	UP_KEYWORDS	UP_SEQ_FEATURE	UP_TISSUE
OAS1	2'-5'-oligoadenylate synthetase 1(OAS1)	Homo sapiens			Dengue Hemorrhagic Fever,diabetes, type 1,Encephalitis, Tick-Borne|Tick-Borne Encephalitis,gamma-Glutamyltransferase,hepatitis B,Hepatitis B, Chronic,hepatitis C,Hepatitis C, Chronic|Liver Cirrhosis,Multiple Sclerosis,ovarian cancer,Severe Acute Respiratory Syndrome,type 1 diabetes,West Nile Fever,	CANCER,IMMUNE,INFECTION,METABOLIC,	GO:0006006~glucose metabolic process,GO:0006164~purine nucleotide biosynthetic process,GO:0006955~immune response,GO:0009615~response to virus,GO:0035457~cellular response to interferon-alpha,GO:0042593~glucose homeostasis,GO:0045071~negative regulation of viral genome replication,GO:0051259~protein oligomerization,GO:0051607~defense response to virus,GO:0060333~interferon-gamma-mediated signaling pathway,GO:0060337~type I interferon signaling pathway,GO:0060700~regulation of ribonuclease activity,	GO:0005576~extracellular region,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005783~endoplasmic reticulum,GO:0005829~cytosol,	GO:0001730~2'-5'-oligoadenylate synthetase activity,GO:0003725~double-stranded RNA binding,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008270~zinc ion binding,GO:0016740~transferase activity,GO:0016779~nucleotidyltransferase activity,GO:0046872~metal ion binding,	IPR002934:Nucleotidyl transferase domain,IPR006116:2-5-oligoadenylate synthetase, N-terminal,IPR006117:2-5-oligoadenylate synthetase, conserved site,IPR018952:2'-5'-oligoadenylate synthetase 1, domain 2/C-terminal,IPR026774:2'-5'-oligoadenylate synthase,	hsa05160:Hepatitis C,hsa05162:Measles,hsa05164:Influenza A,hsa05168:Herpes simplex infection,	222100~Diabetes mellitus, type 1, susceptibility to,Viral infection, susceptibility to~Viral infection, susceptibility to,			3D-structure,Alternative splicing,Antiviral defense,ATP-binding,Complete proteome,Cytoplasm,Endoplasmic reticulum,Immunity,Innate immunity,Magnesium,Metal-binding,Microsome,Mitochondrion,Nucleotide-binding,Nucleotidyltransferase,Nucleus,Polymorphism,Proteomics identification,Reference proteome,RNA-binding,Secreted,Transferase,	chain:2'-5'-oligoadenylate synthetase 1,mutagenesis site,region of interest:Necessary for binding to dsRNA,sequence conflict,sequence variant,splice variant,	Brain,Fetal blood,Liver,Lymphoblast,Small intestine,Uterus,
ADAM15	ADAM metallopeptidase domain 15(ADAM15)	Homo sapiens			Schizophrenia,	PSYCH,	GO:0001525~angiogenesis,GO:0001953~negative regulation of cell-matrix adhesion,GO:0006508~proteolysis,GO:0006915~apoptotic process,GO:0007160~cell-matrix adhesion,GO:0007229~integrin-mediated signaling pathway,GO:0008584~male gonad development,GO:0022617~extracellular matrix disassembly,GO:0030308~negative regulation of cell growth,GO:0030336~negative regulation of cell migration,GO:0030574~collagen catabolic process,GO:0042246~tissue regeneration,GO:0045087~innate immune response,GO:0060317~cardiac epithelial to mesenchymal transition,GO:0070528~protein kinase C signaling,GO:1900121~negative regulation of receptor binding,	GO:0001669~acrosomal vesicle,GO:0005886~plasma membrane,GO:0005912~adherens junction,GO:0009986~cell surface,GO:0016021~integral component of membrane,GO:0042995~cell projection,GO:0070062~extracellular exosome,	GO:0004222~metalloendopeptidase activity,GO:0005178~integrin binding,GO:0005515~protein binding,GO:0008237~metallopeptidase activity,GO:0017124~SH3 domain binding,GO:0046872~metal ion binding,	IPR000742:Epidermal growth factor-like domain,IPR001590:Peptidase M12B, ADAM/reprolysin,IPR001762:Blood coagulation inhibitor, Disintegrin,IPR002870:Peptidase M12B, propeptide,IPR006586:ADAM, cysteine-rich,IPR013032:EGF-like, conserved site,IPR024079:Metallopeptidase, catalytic domain,				SM00050:DISIN,SM00608:ACR,	Alternative splicing,Angiogenesis,Cell adhesion,Cell junction,Cell projection,Cleavage on pair of basic residues,Collagen degradation,Complete proteome,Cytoplasmic vesicle,Disulfide bond,EGF-like domain,Glycoprotein,Hydrolase,Membrane,Metal-binding,Metalloprotease,Phosphoprotein,Polymorphism,Protease,Reference proteome,SH3-binding,Signal,Transmembrane,Transmembrane helix,Zinc,Zymogen,	chain:Disintegrin and metalloproteinase domain- containing protein 15,compositionally biased region:Cys-rich,disulfide bond,domain:Disintegrin,domain:EGF-like,domain:Peptidase M12B,glycosylation site:N-linked (GlcNAc...),metal ion-binding site:Zinc; catalytic,metal ion-binding site:Zinc; in inhibited form,modified residue,sequence conflict,sequence variant,short sequence motif:Cell attachment site,short sequence motif:Cysteine switch,short sequence motif:SH3-binding,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,	Brain,Kidney,Mammary carcinoma,Umbilical vein,
BAK1	BCL2 antagonist/killer 1(BAK1)	Homo sapiens	h_mitochondriaPathway:Role of Mitochondria in Apoptotic Signaling,		Acquired Immunodeficiency Syndrome|Disease Progression,Bladder Cancer,chronic obstructive pulmonary disease,Chronic renal failure|Kidney Failure, Chronic,esophageal adenocarcinoma,hematological parameters,Leukemia, Lymphocytic, Chronic, B-Cell,Lung Cancer,lung cancer ,Lymphoma, Non-Hodgkin,Lymphoma, Non-Hodgkin|Lymphoma, Non-Hodgkin's,lymphoproliferative disorders,null,Platelet Count,testicular germ cell tumor,Testicular Neoplasms,Type 2 Diabetes| edema | rosiglitazone,	CANCER,HEMATOLOGICAL,INFECTION,OTHER,PHARMACOGENOMIC,RENAL,UNKNOWN,	GO:0001782~B cell homeostasis,GO:0001783~B cell apoptotic process,GO:0001836~release of cytochrome c from mitochondria,GO:0001974~blood vessel remodeling,GO:0002262~myeloid cell homeostasis,GO:0002352~B cell negative selection,GO:0006987~activation of signaling protein activity involved in unfolded protein response,GO:0007420~brain development,GO:0007568~aging,GO:0008053~mitochondrial fusion,GO:0008283~cell proliferation,GO:0008285~negative regulation of cell proliferation,GO:0008630~intrinsic apoptotic signaling pathway in response to DNA damage,GO:0008635~activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c,GO:0009620~response to fungus,GO:0010046~response to mycotoxin,GO:0010225~response to UV-C,GO:0010248~establishment or maintenance of transmembrane electrochemical gradient,GO:0010332~response to gamma radiation,GO:0010524~positive regulation of calcium ion transport into cytosol,GO:0010629~negative regulation of gene expression,GO:0014070~response to organic cyclic compound,GO:0019835~cytolysis,GO:0031018~endocrine pancreas development,GO:0031100~organ regeneration,GO:0032469~endoplasmic reticulum calcium ion homeostasis,GO:0032471~negative regulation of endoplasmic reticulum calcium ion concentration,GO:0033137~negative regulation of peptidyl-serine phosphorylation,GO:0034644~cellular response to UV,GO:0035108~limb morphogenesis,GO:0042493~response to drug,GO:0042542~response to hydrogen peroxide,GO:0043065~positive regulation of apoptotic process,GO:0043496~regulation of protein homodimerization activity,GO:0043497~regulation of protein heterodimerization activity,GO:0044346~fibroblast apoptotic process,GO:0045471~response to ethanol,GO:0045862~positive regulation of proteolysis,GO:0046902~regulation of mitochondrial membrane permeability,GO:0048597~post-embryonic camera-type eye morphogenesis,GO:0051726~regulation of cell cycle,GO:0051881~regulation of mitochondrial membrane potential,GO:0060068~vagina development,GO:0070059~intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,GO:0070242~thymocyte apoptotic process,GO:0071260~cellular response to mechanical stimulus,GO:0090200~positive regulation of release of cytochrome c from mitochondria,GO:0097190~apoptotic signaling pathway,GO:0097192~extrinsic apoptotic signaling pathway in absence of ligand,GO:0097202~activation of cysteine-type endopeptidase activity,GO:1900103~positive regulation of endoplasmic reticulum unfolded protein response,GO:1901030~positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,GO:1902262~apoptotic process involved in patterning of blood vessels,GO:1903896~positive regulation of IRE1-mediated unfolded protein response,	GO:0005739~mitochondrion,GO:0005741~mitochondrial outer membrane,GO:0005783~endoplasmic reticulum,GO:0005829~cytosol,GO:0016021~integral component of membrane,GO:0031307~integral component of mitochondrial outer membrane,GO:0046930~pore complex,	GO:0005515~protein binding,GO:0031072~heat shock protein binding,GO:0042802~identical protein binding,GO:0042803~protein homodimerization activity,GO:0044325~ion channel binding,GO:0046872~metal ion binding,GO:0046982~protein heterodimerization activity,GO:0051087~chaperone binding,GO:0051400~BH domain binding,	IPR002475:Bcl2-like,IPR020717:Apoptosis regulator, Bcl-2, BH1 motif, conserved site,IPR020726:Apoptosis regulator, Bcl-2, BH2 motif, conserved site,IPR020728:Apoptosis regulator, Bcl-2, BH3 motif, conserved site,IPR026298:Blc2 family,IPR026308:Apoptosis regulator BAK,	hsa04141:Protein processing in endoplasmic reticulum,hsa05203:Viral carcinogenesis,hsa05206:MicroRNAs in cancer,				3D-structure,Acetylation,Alternative splicing,Apoptosis,Complete proteome,Membrane,Metal-binding,Mitochondrion,Polymorphism,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,Zinc,	chain:Bcl-2 homologous antagonist/killer,chain:Putative Bcl-2 homologous antagonist/killer 2,helix,metal ion-binding site:Zinc; shared with dimeric partner,modified residue,mutagenesis site,sequence variant,short sequence motif:BH1,short sequence motif:BH2,short sequence motif:BH3,transmembrane region,turn,	Amygdala,B-cell,Lung,
CLN3	CLN3, battenin(CLN3)	Homo sapiens			Batten disease,Crohn Disease,HIV Infections|[X]Human immunodeficiency virus disease,inflammatory bowel disease (early onset),Neuronal Ceroid-Lipofuscinoses,	IMMUNE,INFECTION,NEUROLOGICAL,UNKNOWN,	GO:0001508~action potential,GO:0001575~globoside metabolic process,GO:0006520~cellular amino acid metabolic process,GO:0006672~ceramide metabolic process,GO:0006678~glucosylceramide metabolic process,GO:0006681~galactosylceramide metabolic process,GO:0006684~sphingomyelin metabolic process,GO:0006898~receptor-mediated endocytosis,GO:0007034~vacuolar transport,GO:0007040~lysosome organization,GO:0007042~lysosomal lumen acidification,GO:0008306~associative learning,GO:0010468~regulation of gene expression,GO:0015809~arginine transport,GO:0016236~macroautophagy,GO:0016242~negative regulation of macroautophagy,GO:0016485~protein processing,GO:0030163~protein catabolic process,GO:0035235~ionotropic glutamate receptor signaling pathway,GO:0035752~lysosomal lumen pH elevation,GO:0042133~neurotransmitter metabolic process,GO:0042987~amyloid precursor protein catabolic process,GO:0043066~negative regulation of apoptotic process,GO:0043086~negative regulation of catalytic activity,GO:0043524~negative regulation of neuron apoptotic process,GO:0045861~negative regulation of proteolysis,GO:0047496~vesicle transport along microtubule,GO:0050885~neuromuscular process controlling balance,GO:0051480~regulation of cytosolic calcium ion concentration,GO:0061024~membrane organization,GO:0097352~autophagosome maturation,	GO:0000139~Golgi membrane,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005764~lysosome,GO:0005765~lysosomal membrane,GO:0005769~early endosome,GO:0005770~late endosome,GO:0005776~autophagosome,GO:0005783~endoplasmic reticulum,GO:0005794~Golgi apparatus,GO:0005795~Golgi stack,GO:0005802~trans-Golgi network,GO:0005886~plasma membrane,GO:0005901~caveola,GO:0008021~synaptic vesicle,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0030176~integral component of endoplasmic reticulum membrane,GO:0043005~neuron projection,GO:0045121~membrane raft,	GO:0005515~protein binding,GO:0051082~unfolded protein binding,	IPR003492:Batten's disease protein Cln3,IPR018460:Batten's disease protein Cln3, subgroup,IPR020846:Major facilitator superfamily domain,	hsa04142:Lysosome,	204200~Ceroid lipofuscinosis, neuronal, 3,	PIRSF015974:CLN3 protein/Battenin (Batten disease protein),		Alternative splicing,Complete proteome,Disease mutation,Endosome,Glycoprotein,Lipoprotein,Lysosome,Membrane,Methylation,Neurodegeneration,Neuronal ceroid lipofuscinosis,Phosphoprotein,Prenylation,Proteomics identification,Reference proteome,Signal,Transmembrane,Transmembrane helix,Transport,	chain:Battenin,glycosylation site:N-linked (GlcNAc...),modified residue,sequence variant,splice variant,transmembrane region,	Brain,Cerebellum,Epithelium,Lung,
DDRGK1	DDRGK domain containing 1(DDRGK1)	Homo sapiens			hepatitis C, chronic,	INFECTION,	GO:0033146~regulation of intracellular estrogen receptor signaling pathway,GO:0034976~response to endoplasmic reticulum stress,GO:0051092~positive regulation of NF-kappaB transcription factor activity,GO:1901800~positive regulation of proteasomal protein catabolic process,GO:1903721~positive regulation of I-kappaB phosphorylation,GO:1990592~protein K69-linked ufmylation,	GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,	GO:0005515~protein binding,GO:0044389~ubiquitin-like protein ligase binding,	IPR011991:Winged helix-turn-helix DNA-binding domain,IPR019153:DDRGK domain containing protein,				SM01128:SM01128,	Alternative splicing,Coiled coil,Complete proteome,Endoplasmic reticulum,Isopeptide bond,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Signal,Ubl conjugation,	chain:DDRGK domain-containing protein 1,domain:PCI,sequence variant,signal peptide,splice variant,	Brain,Lymph,Uterus,
FAT1	FAT atypical cadherin 1(FAT1)	Homo sapiens			Bipolar Disorder,Blood Pressure Determination,Cholesterol, HDL,Electrocardiography,Hip,null,Obesity,	CARDIOVASCULAR,METABOLIC,PSYCH,UNKNOWN,	GO:0007015~actin filament organization,GO:0007155~cell adhesion,GO:0007156~homophilic cell adhesion via plasma membrane adhesion molecules,GO:0007163~establishment or maintenance of cell polarity,GO:0007267~cell-cell signaling,GO:0009653~anatomical structure morphogenesis,GO:0016337~single organismal cell-cell adhesion,GO:0016477~cell migration,	GO:0005634~nucleus,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0005911~cell-cell junction,GO:0005925~focal adhesion,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0030027~lamellipodium,GO:0030175~filopodium,GO:0048471~perinuclear region of cytoplasm,GO:0070062~extracellular exosome,	GO:0005509~calcium ion binding,GO:0005515~protein binding,	IPR000152:EGF-type aspartate/asparagine hydroxylation site,IPR000742:Epidermal growth factor-like domain,IPR001791:Laminin G domain,IPR001881:EGF-like calcium-binding,IPR002126:Cadherin,IPR013032:EGF-like, conserved site,IPR013320:Concanavalin A-like lectin/glucanase, subgroup,IPR015919:Cadherin-like,IPR018097:EGF-like calcium-binding, conserved site,IPR020894:Cadherin conserved site,				SM00112:CA,SM00179:EGF_CA,SM00181:EGF,SM00282:LamG,	Calcium,Cell adhesion,Cell membrane,Complete proteome,Cytoplasm,Disulfide bond,EGF-like domain,Glycoprotein,Membrane,Nucleus,Polymorphism,Proteomics identification,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:Protocadherin Fat 1,disulfide bond,domain:Cadherin 1,domain:Cadherin 10,domain:Cadherin 11,domain:Cadherin 12,domain:Cadherin 13,domain:Cadherin 14,domain:Cadherin 15,domain:Cadherin 16,domain:Cadherin 17,domain:Cadherin 18,domain:Cadherin 19,domain:Cadherin 2,domain:Cadherin 20,domain:Cadherin 21,domain:Cadherin 22,domain:Cadherin 23,domain:Cadherin 24,domain:Cadherin 25,domain:Cadherin 26,domain:Cadherin 27,domain:Cadherin 28,domain:Cadherin 29,domain:Cadherin 3,domain:Cadherin 30,domain:Cadherin 31,domain:Cadherin 32,domain:Cadherin 33,domain:Cadherin 34,domain:Cadherin 4,domain:Cadherin 5,domain:Cadherin 6,domain:Cadherin 7,domain:Cadherin 8,domain:Cadherin 9,domain:EGF-like 1,domain:EGF-like 2,domain:EGF-like 3,domain:EGF-like 4,domain:EGF-like 5,domain:Laminin G-like,glycosylation site:N-linked (GlcNAc...),modified residue,sequence variant,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,	Epithelium,Liver,Lymphocyte,
ISG15	ISG15 ubiquitin-like modifier(ISG15)	Homo sapiens			Osteoporosis,ovarian cancer,Respiratory Syncytial Virus Infections,Type 2 Diabetes| edema | rosiglitazone,	CANCER,INFECTION,METABOLIC,PHARMACOGENOMIC,	GO:0019941~modification-dependent protein catabolic process,GO:0019985~translesion synthesis,GO:0030501~positive regulation of bone mineralization,GO:0031397~negative regulation of protein ubiquitination,GO:0032020~ISG15-protein conjugation,GO:0032480~negative regulation of type I interferon production,GO:0032649~regulation of interferon-gamma production,GO:0034340~response to type I interferon,GO:0042742~defense response to bacterium,GO:0045071~negative regulation of viral genome replication,GO:0045648~positive regulation of erythrocyte differentiation,GO:0051607~defense response to virus,GO:0060337~type I interferon signaling pathway,	GO:0005576~extracellular region,GO:0005654~nucleoplasm,GO:0005829~cytosol,	GO:0005515~protein binding,GO:0031386~protein tag,	IPR000626:Ubiquitin,IPR019956:Ubiquitin subgroup,	hsa04622:RIG-I-like receptor signaling pathway,	616126~Immunodeficiency 38,		SM00213:UBQ,	3D-structure,Antiviral defense,Complete proteome,Cytoplasm,Direct protein sequencing,Disulfide bond,Host-virus interaction,Immunity,Innate immunity,Isopeptide bond,Polymorphism,Proteomics identification,Reference proteome,Repeat,S-nitrosylation,Secreted,Ubl conjugation pathway,	binding site:Activating enzyme,chain:Interferon-induced 17 kDa protein,chain:Ubiquitin cross-reactive protein,cross-link:Glycyl lysine isopeptide (Gly-Lys) (interchain with K-? in acceptor proteins),domain:Ubiquitin-like 1,domain:Ubiquitin-like 2,helix,propeptide:Removed in mature form,region of interest:Involved in the ligation of specific target proteins,sequence conflict,sequence variant,strand,	Colon,Testis,
MAGEE1	MAGE family member E1(MAGEE1)	Homo sapiens			melanoma,	CANCER,		GO:0005634~nucleus,GO:0005886~plasma membrane,GO:0016010~dystrophin-associated glycoprotein complex,GO:0030425~dendrite,GO:0045211~postsynaptic membrane,GO:0048471~perinuclear region of cytoplasm,	GO:0005515~protein binding,	IPR002190:MAGE protein,				SM01373:SM01373,	3D-structure,Cell membrane,Complete proteome,Cytoplasm,Membrane,Nucleus,Polymorphism,Reference proteome,Repeat,Tumor antigen,Ubl conjugation pathway,	chain:Melanoma-associated antigen E1,compositionally biased region:Pro-rich,domain:MAGE 1,domain:MAGE 2,sequence variant,	Brain,PNS,Testis,
RFESD	Rieske Fe-S domain containing(RFESD)	Homo sapiens					GO:0055114~oxidation-reduction process,		GO:0005515~protein binding,GO:0016491~oxidoreductase activity,GO:0046872~metal ion binding,GO:0051537~2 iron, 2 sulfur cluster binding,	IPR017941:Rieske [2Fe-2S] iron-sulphur domain,					2Fe-2S,Acetylation,Alternative splicing,Complete proteome,Iron,Iron-sulfur,Metal-binding,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,	chain:Rieske domain-containing protein,domain:Rieske 1,domain:Rieske 2,metal ion-binding site:Iron-sulfur (2Fe-2S),metal ion-binding site:Iron-sulfur (2Fe-2S); via pros nitrogen,	Brain,Lung,Testis,
TBC1D2	TBC1 domain family member 2(TBC1D2)	Homo sapiens			Cleft Lip|Cleft Palate,Erythrocyte Count,Hemoglobins,Multiple Sclerosis,	DEVELOPMENTAL,HEMATOLOGICAL,IMMUNE,	GO:0006886~intracellular protein transport,GO:0031338~regulation of vesicle fusion,GO:0043547~positive regulation of GTPase activity,GO:0090630~activation of GTPase activity,GO:1902017~regulation of cilium assembly,	GO:0012505~endomembrane system,GO:0016023~cytoplasmic, membrane-bounded vesicle,GO:0030054~cell junction,GO:0031410~cytoplasmic vesicle,	GO:0005096~GTPase activator activity,GO:0005515~protein binding,GO:0017137~Rab GTPase binding,GO:0045296~cadherin binding,	IPR000195:Rab-GTPase-TBC domain,IPR001849:Pleckstrin homology domain,IPR011993:Pleckstrin homology-like domain,				SM00164:TBC,SM00233:PH,	3D-structure,Acetylation,Alternative splicing,Cell junction,Coiled coil,Complete proteome,Cytoplasm,Cytoplasmic vesicle,GTPase activation,Phosphoprotein,Polymorphism,Reference proteome,	chain:TBC1 domain family member 2A,domain:PH,domain:Rab-GAP TBC,helix,modified residue,sequence conflict,sequence variant,strand,turn,	Amygdala,Brain,Epithelium,
ZBP1	Z-DNA binding protein 1(ZBP1)	Homo sapiens			Body Fat Distribution,Coronary Disease,hippocampal atrophy,Hippocampus,	AGING,CARDIOVASCULAR,METABOLIC,NEUROLOGICAL,	GO:0032481~positive regulation of type I interferon production,GO:0045087~innate immune response,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0003677~DNA binding,GO:0003692~left-handed Z-DNA binding,GO:0003723~RNA binding,GO:0003726~double-stranded RNA adenosine deaminase activity,GO:0005515~protein binding,	IPR000607:Double-stranded RNA-specific adenosine deaminase (DRADA),IPR011991:Winged helix-turn-helix DNA-binding domain,	hsa04623:Cytosolic DNA-sensing pathway,			SM00550:Zalpha,	3D-structure,Alternative splicing,Complete proteome,DNA-binding,Immunity,Innate immunity,Polymorphism,Reference proteome,Repeat,	chain:Z-DNA-binding protein 1,helix,repeat:DRADA 1,repeat:DRADA 2,sequence conflict,sequence variant,splice variant,strand,turn,	Blood,Spleen,
ALS2CR12	amyotrophic lateral sclerosis 2 chromosome region candidate 12(ALS2CR12)	Homo sapiens			benzene haematotoxicity,Bladder Cancer,Carcinoma, Squamous Cell|Esophageal Neoplasms,melanoma,Tobacco Use Disorder,	CANCER,CHEMDEPENDENCY,PHARMACOGENOMIC,	GO:0043087~regulation of GTPase activity,	GO:0001520~outer dense fiber,GO:0005737~cytoplasm,GO:0035686~sperm fibrous sheath,	GO:0005515~protein binding,	IPR026674:Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 12 protein,					Acetylation,Alternative splicing,Coiled coil,Complete proteome,Polymorphism,Proteomics identification,Reference proteome,	chain:Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 12 protein,modified residue,sequence variant,	Brain,Testis,
BATF2	basic leucine zipper ATF-like transcription factor 2(BATF2)	Homo sapiens					GO:0006351~transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0042832~defense response to protozoan,GO:0043011~myeloid dendritic cell differentiation,	GO:0005634~nucleus,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000982~transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0043565~sequence-specific DNA binding,	IPR000837:Fos transforming protein,IPR004827:Basic-leucine zipper domain,				SM00338:BRLZ,	Activator,Alternative splicing,Coiled coil,Complete proteome,Differentiation,DNA-binding,Nucleus,Polymorphism,Reference proteome,Transcription,Transcription regulation,	chain:Basic leucine zipper transcriptional factor ATF-like 2,DNA-binding region:Basic motif,domain:Leucine-zipper,sequence variant,splice variant,	Lung,Pericardium,Placenta,Small intestine,
EPSTI1	epithelial stromal interaction 1(EPSTI1)	Homo sapiens								IPR026185:Epithelial-stromal interaction protein 1,					Alternative splicing,Coiled coil,Complete proteome,Proteomics identification,Reference proteome,	chain:Epithelial-stromal interaction protein 1,sequence conflict,splice variant,	Colon,Lymph node,Mammary gland,Testis,
FBP1	fructose-bisphosphatase 1(FBP1)	Homo sapiens			Cleft Lip|Cleft Palate|Tooth Abnormalities,plasma HDL cholesterol (HDL-C) levels,Schizophrenia,	DEVELOPMENTAL,METABOLIC,PSYCH,	GO:0005986~sucrose biosynthetic process,GO:0006000~fructose metabolic process,GO:0006001~fructose catabolic process,GO:0006002~fructose 6-phosphate metabolic process,GO:0006094~gluconeogenesis,GO:0006111~regulation of gluconeogenesis,GO:0016311~dephosphorylation,GO:0030308~negative regulation of cell growth,GO:0030388~fructose 1,6-bisphosphate metabolic process,GO:0035690~cellular response to drug,GO:0045820~negative regulation of glycolytic process,GO:0046580~negative regulation of Ras protein signal transduction,GO:0051289~protein homotetramerization,GO:0071286~cellular response to magnesium ion,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0070062~extracellular exosome,	GO:0005515~protein binding,GO:0016208~AMP binding,GO:0042132~fructose 1,6-bisphosphate 1-phosphatase activity,GO:0042802~identical protein binding,GO:0046872~metal ion binding,GO:0048029~monosaccharide binding,	IPR000146:Fructose-1,6-bisphosphatase class 1/Sedoheputulose-1,7-bisphosphatase,IPR020548:Fructose-1,6-bisphosphatase, active site,	hsa00010:Glycolysis / Gluconeogenesis,hsa00030:Pentose phosphate pathway,hsa00051:Fructose and mannose metabolism,hsa01100:Metabolic pathways,hsa01130:Biosynthesis of antibiotics,hsa01200:Carbon metabolism,hsa04152:AMPK signaling pathway,hsa04910:Insulin signaling pathway,	229700~Fructose-1,6-bisphosphatase deficiency,	PIRSF000904:fructose-1,6-bisphosphatase/sedoheptulose-1,7-bisphosphatase,PIRSF500210:fructose-1,6-bisphosphatase [Parent=PIRSF000904],		3D-structure,Acetylation,Allosteric enzyme,Carbohydrate metabolism,Complete proteome,Direct protein sequencing,Disease mutation,Gluconeogenesis,Hydrolase,Magnesium,Metal-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	binding site:AMP,binding site:Substrate,chain:Fructose-1,6-bisphosphatase 1,helix,metal ion-binding site:Magnesium 1,metal ion-binding site:Magnesium 2,metal ion-binding site:Magnesium 2; via carbonyl oxygen,metal ion-binding site:Magnesium 3,modified residue,mutagenesis site,nucleotide phosphate-binding region:AMP,region of interest:Substrate binding,sequence conflict,sequence variant,strand,turn,	Colon,Kidney,Liver,Lung,Monocyte,Thymus,Urinary bladder,
IFI44L	interferon induced protein 44 like(IFI44L)	Homo sapiens		Cell division and chromosome partitioning / Cytoskeleton,			GO:0051607~defense response to virus,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,	GO:0005525~GTP binding,	IPR006073:GTP binding domain,IPR024644:Interferon-induced protein 44 family,IPR027417:P-loop containing nucleoside triphosphate hydrolase,					Alternative splicing,Antiviral defense,Complete proteome,Cytoplasm,Polymorphism,Proteomics identification,Reference proteome,	chain:Interferon-induced protein 44-like,sequence conflict,sequence variant,splice variant,	Cancellous bone,Spinal cord,Uterus,
KBTBD6	kelch repeat and BTB domain containing 6(KBTBD6)	Homo sapiens					GO:0016567~protein ubiquitination,	GO:0016021~integral component of membrane,GO:0031463~Cul3-RING ubiquitin ligase complex,	GO:0004842~ubiquitin-protein transferase activity,GO:0005515~protein binding,	IPR000210:BTB/POZ-like,IPR006652:Kelch repeat type 1,IPR011333:BTB/POZ fold,IPR011705:BTB/Kelch-associated,IPR015915:Kelch-type beta propeller,				SM00225:BTB,SM00612:Kelch,SM00875:SM00875,	3D-structure,Complete proteome,Kelch repeat,Membrane,Reference proteome,Repeat,Transmembrane,Transmembrane helix,	chain:Kelch repeat and BTB domain-containing protein 6,domain:BTB,repeat:Kelch 1,repeat:Kelch 2,repeat:Kelch 3,repeat:Kelch 4,repeat:Kelch 5,repeat:Kelch 6,sequence conflict,	Brain,Prostate,
LINC00482	long intergenic non-protein coding RNA 482(LINC00482)	Homo sapiens							GO:0005515~protein binding,						Complete proteome,Polymorphism,Reference proteome,	chain:Uncharacterized protein C17orf55,sequence variant,	Placenta,
MFSD7	major facilitator superfamily domain containing 7(MFSD7)	Homo sapiens					GO:0055085~transmembrane transport,	GO:0016021~integral component of membrane,		IPR011701:Major facilitator superfamily,IPR020846:Major facilitator superfamily domain,					Alternative splicing,Complete proteome,Membrane,Polymorphism,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,Transport,	chain:Major facilitator superfamily domain- containing protein 7,sequence conflict,sequence variant,splice variant,transmembrane region,	Blood,Spleen,
MAOA	monoamine oxidase A(MAOA)	Homo sapiens			ADHD,ADHD | attention deficit hyperactivity disorder,ADHD | attention-deficit hyperactivity disorder,aggression, impulsivity, and central nervous system serotonergic responsivity,aggressive behavior,aggressive behavior Fragile X Syndrome,alcohol,alcohol abuse,alcohol consumption,alcohol dependence impulsive behaviors,Alcohol-Related Disorders,Alcoholism,alcoholism antisocial personality disorder,alcoholism body mass dopamine,alcoholism personality disorders,Alzheimer's Disease,Alzheimer's disease   ,Alzheimer's disease; Parkinson's disease,antisocial behavior,antisocial behavioural traits,antisocial personality disorder,antisocial personality disorder conduct disorder,anxiety disorder,anxiety disorder; depressive disorder, major; panic disorder,attention deficit disorder,attention deficit disorder conduct disorder oppositional defiant disorder,attention deficit hyperactivity disorder,auditory evoked potentials,autism,behavior traits,behavioural traits,bipolar affective disorder,Bipolar Disorder,bipolar disorder; depression,bipolar disorder; major depressive disorder,bipolar disorder; major depressive disorder; rapid cycling mood disorder,Bladder Cancer,BMI,body mass obesity,BP-Major Depressive,Bulimia,Child Temperament,chronic fatigue syndrome,citalopram,cognitive function,Conduct Disorder,Coronary Disease,Coronary Disease|Coronary heart disease|Metabolic Syndrome X,Coronary Restenosis|Postoperative Complications,criminal activity,criminal behavior,criminality,cytogenetic studies,decision making,Deliberate self-harm,dementia,depressed suicide,Depression,depression sleep disorders,Depression, Postpartum|,depression; thrombocyte MAO activity,Depressive Disorder, Major,depressive disorder, major endocrine regulation,depressive disorder, major; bipolar disorder,depressive disorder, major; nausea,Diseases in Twins,Diseases in Twins|Sex Chromosome Aberrations,early onset alcoholism/substance abuse.,endurance performance,epilepsy,epilepsy, temporal lobe,Fatigue Syndrome, Chronic|fatigue syndrome; postviral,Fatigue|Fatigue Syndrome, Chronic,Fibromyalgia,financial and psychological risk attitudes,Gout,headache,heroin addiction,Heroin Dependence,impulsive behavior,Lung Cancer,lung cancer ,major depressive disorder,manic-depressive illness,mental retardation,migraine,migraine ,Migraine Disorders,Migraine Disorders|Substance-Related Disorders,migraine; migraine with aura,monoamine metabolites,mood disorder,mood disorders,narcolepsy-cataplexy symptoms,neuroticism,nicotine dependence; cotinine,normal variation,null,Obesity,Obesity|Overweight,Obesity|POF - Premature ovarian failure|POLYCYSTIC OVARIAN SYNDROME|Polycystic Ovary Syndrome|Primary Ovarian Insufficiency|Puberty, Delayed|Puberty, Precocious|Thrombophilia|Tobacco Use Disorder,obsessive Compulsive Disorder,obsessive-compulsive disorder,pain response,panic disorder,Parkinson's Disease,Parkinson's disease    ,pathologic gambling,personality,personality disorders,personality traits,physical agression,Pregnancy Complications|Prenatal Exposure Delayed Effects|Serotonin Syndrome,premenstrual dysphoric disorder,prostate cancer,Psychiatric Disorders,psychopathology,Psychoses, Substance-Induced|Substance-Related Disorders,Restless Legs Syndrome,risperidone-induced extrapyramidal symptoms,Schizophrenia,schizophrenia with aggressive behavior,schizophrenia; affective disorder,schizophrenia; psychoses; aggressive behavior; verbal fluency,self-harm behavior,serotonin,several psychiatric disorders,shyness,Sleep Disorders,sleep disorders; depressive disorder, major,smoking,smoking behavior,Substance-Related Disorders,Sudden Infant Death,suicide,tardive dyskinesia,Tourette Syndrome,Type 2 Diabetes| edema | rosiglitazone,Weight Gain,	CANCER,CARDIOVASCULAR,CHEMDEPENDENCY,DEVELOPMENTAL,METABOLIC,NEUROLOGICAL,NORMALVARIATION,OTHER,PHARMACOGENOMIC,PSYCH,REPRODUCTION,UNKNOWN,	GO:0006576~cellular biogenic amine metabolic process,GO:0042133~neurotransmitter metabolic process,GO:0042135~neurotransmitter catabolic process,GO:0042420~dopamine catabolic process,GO:0055114~oxidation-reduction process,	GO:0005739~mitochondrion,GO:0005741~mitochondrial outer membrane,GO:0016021~integral component of membrane,	GO:0008131~primary amine oxidase activity,GO:0016491~oxidoreductase activity,	IPR001613:Flavin amine oxidase,IPR002937:Amine oxidase,IPR023753:Pyridine nucleotide-disulphide oxidoreductase, FAD/NAD(P)-binding domain,	hsa00260:Glycine, serine and threonine metabolism,hsa00330:Arginine and proline metabolism,hsa00340:Histidine metabolism,hsa00350:Tyrosine metabolism,hsa00360:Phenylalanine metabolism,hsa00380:Tryptophan metabolism,hsa00982:Drug metabolism - cytochrome P450,hsa01100:Metabolic pathways,hsa04726:Serotonergic synapse,hsa04728:Dopaminergic synapse,hsa05030:Cocaine addiction,hsa05031:Amphetamine addiction,hsa05034:Alcoholism,	300615~Brunner syndrome,			3D-structure,Acetylation,Alternative splicing,Catecholamine metabolism,Complete proteome,Direct protein sequencing,Disease mutation,FAD,Flavoprotein,Membrane,Mental retardation,Mitochondrion,Mitochondrion outer membrane,Neurotransmitter degradation,Oxidoreductase,Phosphoprotein,Polymorphism,Reference proteome,Transmembrane,Transmembrane helix,	chain:Amine oxidase [flavin-containing] A,helix,modified residue,mutagenesis site,region of interest:Interaction with membrane phospholipid headgroups,sequence conflict,sequence variant,site:Important for catalytic activity,site:Important for substrate specificity,strand,topological domain:Cytoplasmic,topological domain:Mitochondrial intermembrane,transmembrane region,turn,	Adipose tissue,Liver,Ovary,Placenta,Testis,
PHLDB2	pleckstrin homology like domain family B member 2(PHLDB2)	Homo sapiens		Cell division and chromosome partitioning,	Cognitive performance ,Tobacco Use Disorder,	CHEMDEPENDENCY,NEUROLOGICAL,	GO:0000226~microtubule cytoskeleton organization,GO:0010470~regulation of gastrulation,GO:0010717~regulation of epithelial to mesenchymal transition,GO:0045184~establishment of protein localization,GO:0051497~negative regulation of stress fiber assembly,GO:0051895~negative regulation of focal adhesion assembly,GO:0070507~regulation of microtubule cytoskeleton organization,GO:0098609~cell-cell adhesion,GO:1903690~negative regulation of wound healing, spreading of epidermal cells,GO:1904261~positive regulation of basement membrane assembly involved in embryonic body morphogenesis,	GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0005913~cell-cell adherens junction,GO:0005925~focal adhesion,GO:0016021~integral component of membrane,GO:0031252~cell leading edge,GO:0045111~intermediate filament cytoskeleton,GO:0045180~basal cortex,	GO:0005515~protein binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR001849:Pleckstrin homology domain,IPR011993:Pleckstrin homology-like domain,				SM00233:PH,	Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	chain:PI-PLC X domain-containing protein 2,chain:Pleckstrin homology-like domain family B member 2,domain:PH,domain:PI-PLC X-box,modified residue,mutagenesis site,sequence conflict,sequence variant,splice variant,	Aortic endothelium,Brain,Cervix,Epithelium,Fetal kidney,Heart,Lung,Placenta,Spleen,Testis,Uterus endothel,
RSAD2	radical S-adenosyl methionine domain containing 2(RSAD2)	Homo sapiens			ovarian cancer,	CANCER,	GO:0009615~response to virus,GO:0034157~positive regulation of toll-like receptor 7 signaling pathway,GO:0034165~positive regulation of toll-like receptor 9 signaling pathway,GO:0035710~CD4-positive, alpha-beta T cell activation,GO:0043367~CD4-positive, alpha-beta T cell differentiation,GO:0045071~negative regulation of viral genome replication,GO:0050709~negative regulation of protein secretion,GO:0051607~defense response to virus,GO:0060337~type I interferon signaling pathway,GO:2000553~positive regulation of T-helper 2 cell cytokine production,	GO:0005739~mitochondrion,GO:0005741~mitochondrial outer membrane,GO:0005743~mitochondrial inner membrane,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0005794~Golgi apparatus,GO:0005811~lipid particle,	GO:0003824~catalytic activity,GO:0005515~protein binding,GO:0043621~protein self-association,GO:0046872~metal ion binding,GO:0051536~iron-sulfur cluster binding,GO:0051539~4 iron, 4 sulfur cluster binding,	IPR006638:Elongator protein 3/MiaB/NifB,IPR007197:Radical SAM,IPR013785:Aldolase-type TIM barrel,IPR026372:Antiviral radical SAM protein viperin,	hsa05164:Influenza A,			SM00729:Elp3,	4Fe-4S,Antiviral defense,Atherosclerosis,Complete proteome,Endoplasmic reticulum,Golgi apparatus,Host-virus interaction,Immunity,Innate immunity,Iron,Iron-sulfur,Lipid droplet,Membrane,Metal-binding,Mitochondrion,Mitochondrion inner membrane,Mitochondrion outer membrane,Polymorphism,Proteomics identification,Reference proteome,S-adenosyl-L-methionine,	chain:Radical S-adenosyl methionine domain- containing protein 2,metal ion-binding site:Iron-sulfur (4Fe-4S-S-AdoMet),sequence conflict,sequence variant,	Foreskin fibroblast,Macrophage,Prostate,
SIGLEC1	sialic acid binding Ig like lectin 1(SIGLEC1)	Homo sapiens			longevity,	AGING,	GO:0006897~endocytosis,GO:0006954~inflammatory response,GO:0007160~cell-matrix adhesion,GO:0016337~single organismal cell-cell adhesion,	GO:0005576~extracellular region,GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0030246~carbohydrate binding,	IPR003598:Immunoglobulin subtype 2,IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR013098:Immunoglobulin I-set,IPR013106:Immunoglobulin V-set,IPR013162:CD80-like, immunoglobulin C2-set,IPR013783:Immunoglobulin-like fold,	hsa04514:Cell adhesion molecules (CAMs),			SM00408:IGc2,SM00409:IG,	Alternative splicing,Cell adhesion,Cell membrane,Complete proteome,Disulfide bond,Endocytosis,Glycoprotein,Immunoglobulin domain,Lectin,Membrane,Polymorphism,Proteomics identification,Reference proteome,Repeat,Secreted,Signal,Transmembrane,Transmembrane helix,	binding site:Sialic acid,chain:Sialoadhesin,disulfide bond,domain:Ig-like C2-type 1,domain:Ig-like C2-type 10,domain:Ig-like C2-type 11,domain:Ig-like C2-type 12,domain:Ig-like C2-type 13,domain:Ig-like C2-type 14,domain:Ig-like C2-type 15,domain:Ig-like C2-type 16,domain:Ig-like C2-type 2,domain:Ig-like C2-type 3,domain:Ig-like C2-type 4,domain:Ig-like C2-type 5,domain:Ig-like C2-type 6,domain:Ig-like C2-type 7,domain:Ig-like C2-type 8,domain:Ig-like C2-type 9,domain:Ig-like V-type,glycosylation site:N-linked (GlcNAc...),region of interest:Sialic acid binding,sequence conflict,sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,	Monocyte,Spleen,Thymus,
TCN2	transcobalamin 2(TCN2)	Homo sapiens			1-carbon metabolism,Adenocarcinoma|Stomach Neoplasms,Alcoholism,Alzheimer's Disease,Anemia, Iron-Deficiency|Avitaminosis,Aortic Aneurysm, Abdominal|,Apoplexy|Brain Ischemia|Stroke,atherosclerosis,betaine choline creatinine cystathionine cysteine dimethyglycine folate homocysteine methionine methylmalonic acid vitamin B12 vitamin B2 vitamin B6,brain cancer,Brain Neoplasms|Meningioma,cardiac defects,Central Nervous System Neoplasms|Central Nervous System Tumors|Lymphoma,Central Nervous System Neoplasms|Lymphoma,cerebrovascular disease, ischemic,Cerebrovascular Disorders,Chronic renal failure|Kidney Failure, Chronic,cleft lip with cleft palate cleft lip without cleft palate,Cleft Lip|Cleft Palate,Cleft Lip|Cleft Palate|,Colitis, Ulcerative,Colorectal Cancer,Congenital Abnormalities|,Congenital Heart Defects|Heart Defects, Congenital,Congenital Heart Defects|Heart Defects, Congenital|Obesity,Connective Tissue Diseases|Fetal Diseases|Inflammation|Musculoskeletal Diseases|Pregnancy Complications, Hematologic|Premature Birth|Skin Diseases,Down Syndrome,female infertility,folate homocysteine vitamin B12,Heart Defects, Congenital|Hyperhomocysteinemia,homocysteine; vitamin B12; holotranscobalamin; methylmalonic acid,hyperhomocysteinemia,Infection|Inflammation|Premature Birth,Inflammation|Premature Birth,Intracranial Aneurysm,kidney transplant complications,malaria, plasmodium falciparum,Neural Tube Defects,neural tube defects   ,null,omphalocele,orofacial clefts,oxidative stress,pregnancy loss, second trimester,Premature Birth,prostate cancer,Spinal Dysraphism,spontaneous abortion,vascular disease,	CANCER,CARDIOVASCULAR,CHEMDEPENDENCY,DEVELOPMENTAL,HEMATOLOGICAL,IMMUNE,INFECTION,METABOLIC,NEUROLOGICAL,RENAL,REPRODUCTION,UNKNOWN,	GO:0006824~cobalt ion transport,GO:0009235~cobalamin metabolic process,GO:0015889~cobalamin transport,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005768~endosome,GO:0043202~lysosomal lumen,GO:0070062~extracellular exosome,	GO:0031419~cobalamin binding,GO:0046872~metal ion binding,	IPR002157:Cobalamin (vitamin B12)-binding transporter, eukaryotic,IPR008930:Terpenoid cyclases/protein prenyltransferase alpha-alpha toroid,	hsa04977:Vitamin digestion and absorption,	275350~Transcobalamin II deficiency,			3D-structure,Alternative splicing,Cobalt,Cobalt transport,Complete proteome,Direct protein sequencing,Disulfide bond,Ion transport,Metal-binding,Polymorphism,Proteomics identification,Reference proteome,Secreted,Signal,Transport,	chain:Transcobalamin-2,disulfide bond,helix,sequence variant,signal peptide,strand,turn,	Brain,Eye,
ZNF286B	zinc finger protein 286B(ZNF286B)	Homo sapiens			Blood Pressure,Cholesterol,Erythrocyte Indices,Glucose,Insulin,Insulin Resistance,Lipoprotein(a),	CARDIOVASCULAR,HEMATOLOGICAL,METABOLIC,	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,	GO:0005634~nucleus,	GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0046872~metal ion binding,	IPR007087:Zinc finger, C2H2,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,				SM00355:ZnF_C2H2,	Complete proteome,DNA-binding,Metal-binding,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,Transcription,Transcription regulation,Zinc,Zinc-finger,
